$DCTH
Delcath Systems Inc

2020 Q3 Form 10-Q Financial Statement

#000156459020040037 Filed on August 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q2 2019 Q2
Revenue $470.0K $380.0K $410.0K
YoY Change 23.68% -7.32% -52.21%
Cost Of Revenue $190.0K $168.0K $172.0K
YoY Change 11.76% -2.33% -21.82%
Gross Profit $280.0K $211.0K $240.0K
YoY Change 34.62% -12.08% -62.38%
Gross Profit Margin 59.57% 55.53% 58.54%
Selling, General & Admin $2.000M $2.257M $2.653M
YoY Change -50.02% -14.93% 0.49%
% of Gross Profit 714.29% 1069.67% 1105.42%
Research & Development $3.260M $2.223M $1.714M
YoY Change 83.15% 29.7% -58.08%
% of Gross Profit 1164.29% 1053.55% 714.17%
Depreciation & Amortization $40.00K $40.00K $100.0K
YoY Change -60.0% -60.0% 0.0%
% of Gross Profit 14.29% 18.96% 41.67%
Operating Expenses $5.260M $4.480M $4.367M
YoY Change -9.0% 2.59% -35.11%
Operating Profit -$4.980M -$4.269M -$4.127M
YoY Change -10.62% 3.44% -32.26%
Interest Expense -$40.00K -$52.00K -$1.837M
YoY Change -97.95% -97.17% 228.04%
% of Operating Profit
Other Income/Expense, Net $33.00K $50.00K $1.000K
YoY Change 725.0% 4900.0% -120.0%
Pretax Income -$4.990M -$4.280M -$5.960M
YoY Change -33.64% -28.19% -10.51%
Income Tax
% Of Pretax Income
Net Earnings -$4.991M -$4.275M -$5.959M
YoY Change -33.63% -28.26% -10.5%
Net Earnings / Revenue -1061.91% -1125.0% -1453.41%
Basic Earnings Per Share -$1.90 -$58.50
Diluted Earnings Per Share -$1.163M -$1.90 -$58.50
COMMON SHARES
Basic Shares Outstanding 3.936M 2.273M 101.9K
Diluted Shares Outstanding 2.273M 101.9K

Balance Sheet

Concept 2020 Q3 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.90M $16.01M $350.0K
YoY Change -28.9% 4474.29% -72.66%
Cash & Equivalents $11.08M $16.01M $352.0K
Short-Term Investments
Other Short-Term Assets $2.040M $2.170M $1.720M
YoY Change 96.15% 26.16% 21.99%
Inventory $840.0K $723.0K $687.0K
Prepaid Expenses
Receivables $100.0K $147.0K $180.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $13.88M $19.05M $2.945M
YoY Change -18.97% 546.99% -32.61%
LONG-TERM ASSETS
Property, Plant & Equipment $2.420M $864.0K $805.0K
YoY Change 36.72% 7.33% -26.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $270.0K
YoY Change
Total Long-Term Assets $2.690M $1.389M $2.691M
YoY Change 52.41% -48.38% 143.97%
TOTAL ASSETS
Total Short-Term Assets $13.88M $19.05M $2.945M
Total Long-Term Assets $2.690M $1.389M $2.691M
Total Assets $16.57M $20.44M $5.636M
YoY Change -12.3% 262.72% 2.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.500M $2.174M $10.71M
YoY Change -69.21% -79.71% 91.06%
Accrued Expenses $6.640M $5.429M $9.119M
YoY Change 1.58% -40.46% 74.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $9.840M
YoY Change -100.0%
Long-Term Debt Due $2.000M $520.0K
YoY Change 33.33%
Total Short-Term Liabilities $10.64M $8.111M $31.25M
YoY Change -67.23% -74.05% 72.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $2.000M $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $2.650M $2.630M $122.0K
YoY Change -18.46% 2055.74% -72.21%
Total Long-Term Liabilities $2.650M $4.630M $122.0K
YoY Change -49.52% 3695.08% -72.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.64M $8.111M $31.25M
Total Long-Term Liabilities $2.650M $4.630M $122.0K
Total Liabilities $13.29M $12.74M $35.37M
YoY Change -64.77% -63.97% 90.51%
SHAREHOLDERS EQUITY
Retained Earnings -$383.3M -$357.9M
YoY Change 7.1% 10.36%
Common Stock $35.00K $183.0K
YoY Change -80.87% 1933.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.276M $7.702M -$29.73M
YoY Change
Total Liabilities & Shareholders Equity $16.57M $20.44M $5.636M
YoY Change -12.3% 262.72% 2.98%

Cashflow Statement

Concept 2020 Q3 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$4.991M -$4.275M -$5.959M
YoY Change -33.63% -28.26% -10.5%
Depreciation, Depletion And Amortization $40.00K $40.00K $100.0K
YoY Change -60.0% -60.0% 0.0%
Cash From Operating Activities -$5.190M -$7.850M -$3.190M
YoY Change -58.01% 146.08% 12.32%
INVESTING ACTIVITIES
Capital Expenditures -$490.0K -$40.00K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$490.0K -$40.00K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 660.0K 19.37M 3.320M
YoY Change -97.51% 483.43% 38.33%
NET CHANGE
Cash From Operating Activities -5.190M -7.850M -3.190M
Cash From Investing Activities -490.0K -40.00K 0.000
Cash From Financing Activities 660.0K 19.37M 3.320M
Net Change In Cash -5.020M 11.48M 130.0K
YoY Change -135.6% 8730.77% -127.66%
FREE CASH FLOW
Cash From Operating Activities -$5.190M -$7.850M -$3.190M
Capital Expenditures -$490.0K -$40.00K $0.00
Free Cash Flow -$4.700M -$7.810M -$3.190M
YoY Change -61.97% 144.83% 13.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
4480000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4269000
us-gaap Operating Income Loss
OperatingIncomeLoss
-9344000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2832000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-17000
CY2019Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity File Number
EntityFileNumber
001-16133
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67091
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
172000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67091
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
41517
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
41517
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Cost Of Revenue
CostOfRevenue
246000
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2653000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4573000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
4367000
us-gaap Operating Expenses
OperatingExpenses
9770000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4127000
CY2020Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
46000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15512000
CY2020Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2613000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
508000
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 22C
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei City Area Code
CityAreaCode
212
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
06-1245881
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10019
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3935968
dei Local Phone Number
LocalPhoneNumber
489-2100
dei Entity Shell Company
EntityShellCompany
false
dei Entity Address Address Line1
EntityAddressAddressLine1
1633 Broadway
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16011000
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10002000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
664000
CY2019Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3368000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8111000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
197000
CY2020Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
2000000
CY2019Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
2000000
dei Security12b Title
Security12bTitle
Common stock
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
147000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
181000
dei Trading Symbol
TradingSymbol
DCTH
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
181000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21000
CY2020Q2 us-gaap Inventory Net
InventoryNet
723000
CY2019Q4 us-gaap Inventory Net
InventoryNet
654000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
12617000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
864000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
525000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2174000
CY2019Q4 us-gaap Assets
Assets
14212000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6947000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1759000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
860000
CY2020Q2 us-gaap Assets
Assets
20443000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
735000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4533000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5429000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1992000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
19054000
CY2019Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1837000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-109000
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-52000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
364785000
dei Amendment Flag
AmendmentFlag
false
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-371171000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
28000
CY2019Q4 us-gaap Liabilities
Liabilities
20569000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-6357000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14212000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5011000
us-gaap Gross Profit
GrossProfit
414000
us-gaap Cost Of Revenue
CostOfRevenue
268000
us-gaap Operating Expenses
OperatingExpenses
10214000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5203000
us-gaap Operating Income Loss
OperatingIncomeLoss
-9800000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-134.55
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
102956
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
102956
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-13853000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13927000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-134.55
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2223000
us-gaap Gross Profit
GrossProfit
426000
CY2019Q2 us-gaap Gross Profit
GrossProfit
240000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17000
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
25950
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3521641
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3521641
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
92000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20443000
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2860000
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
25950
CY2020Q2 us-gaap Liabilities
Liabilities
12741000
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
35000
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
390882000
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
168000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-383307000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
7702000
CY2020Q2 us-gaap Gross Profit
GrossProfit
211000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-23778000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
75000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5197000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-4275000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-5959000
us-gaap Net Income Loss
NetIncomeLoss
-12136000
us-gaap Net Income Loss
NetIncomeLoss
-13853000
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4330000
CY2019Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5959000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-12191000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-74000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2257000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1714000
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
606000
CY2019Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10000
CY2019Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
6000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
6000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4064000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
65000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12071000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-10.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-10.40
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1171994
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1171994
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-7861000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
65000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-8005000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-14939000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
54000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-7894000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
7000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
149000
CY2020Q2 us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
-55000
us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
-55000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1000
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-23000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4276000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5982000
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.90
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-58.50
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.90
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-58.50
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2273187
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101862
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2273187
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101862
CY2019Q4 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
1:700
CY2019Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.00142
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
25000
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
30000
CY2020Q1 dcth Adjustment To Additional Paid In Capital Registration Of Preferred Stock And Related Warrants
AdjustmentToAdditionalPaidInCapitalRegistrationOfPreferredStockAndRelatedWarrants
-106000
CY2020Q1 dcth Adjustments To Additional Paid In Capital Fair Value Of Warrants Reclassified From Liability To Equity
AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsReclassifiedFromLiabilityToEquity
6199000
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
-1000
CY2020Q2 dcth Issuance Of Common Stock And Warrants In Public Offering
IssuanceOfCommonStockAndWarrantsInPublicOffering
19378000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1000
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
4000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
150000
CY2019Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
-1160000
CY2019Q2 dcth Stock Issued During Period Value Exchange Of Warrants For Common Stock
StockIssuedDuringPeriodValueExchangeOfWarrantsForCommonStock
13000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-80000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-29729000
dcth Stock Option Compensation Income Expense
StockOptionCompensationIncomeExpense
25000
dcth Stock Option Compensation Income Expense
StockOptionCompensationIncomeExpense
129000
dcth Restricted Stock Compensation Income Expense
RestrictedStockCompensationIncomeExpense
635000
dcth Restricted Stock Compensation Income Expense
RestrictedStockCompensationIncomeExpense
4000
us-gaap Depreciation
Depreciation
92000
us-gaap Depreciation
Depreciation
122000
dcth Amortization Of Right Of Use Assets
AmortizationOfRightOfUseAssets
335000
dcth Amortization Of Right Of Use Assets
AmortizationOfRightOfUseAssets
552000
dcth Loss On Issuance Of Financial Instruments
LossOnIssuanceOfFinancialInstruments
0
dcth Loss On Issuance Of Financial Instruments
LossOnIssuanceOfFinancialInstruments
6000
us-gaap Paid In Kind Interest
PaidInKindInterest
80000
us-gaap Paid In Kind Interest
PaidInKindInterest
329000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3444000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
232000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-232000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
125000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-404000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
70000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-143000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3957000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3827000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-248000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-240000
dcth Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-313000
dcth Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-540000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1416000
dcth Reclassification Of Warrants From Liability To Equity
ReclassificationOfWarrantsFromLiabilityToEquity
6199000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
23000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0
dcth Property Plant And Equipment Depreciation Expense
PropertyPlantAndEquipmentDepreciationExpense
92000000
dcth Finance Lease Principal Payment On Liability
FinanceLeasePrincipalPaymentOnLiability
22000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-504000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13082000
dcth Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
2601900
dcth Class Of Warrant Or Right Exercises In Period
ClassOfWarrantOrRightExercisesInPeriod
6000
dcth Class Of Warrant Or Right Expired In Period
ClassOfWarrantOrRightExpiredInPeriod
9
CY2020Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4422499
CY2020Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10.00
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5962000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
221000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-221000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2000
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2379000
CY2020Q2 us-gaap Lease Cost
LeaseCost
0
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
3719000
us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
106000
us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
0
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
19378000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19249000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3869000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
63000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-69000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6009000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2162000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10183000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3578000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16192000
us-gaap Interest Paid Net
InterestPaidNet
7000
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
15000
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0
dcth Reclassification Of Warrants From Liability To Equity
ReclassificationOfWarrantsFromLiabilityToEquity
0
dcth Exchange Of Warrants
ExchangeOfWarrants
0
dcth Exchange Of Warrants
ExchangeOfWarrants
13000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1652000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
874000
CY2020Q2 dcth Letters Of Credit Restricted Cash
LettersOfCreditRestrictedCash
131000
CY2019Q4 dcth Letters Of Credit Restricted Cash
LettersOfCreditRestrictedCash
131000
CY2020Q2 dcth Security For Credit Cards Restricted Cash
SecurityForCreditCardsRestrictedCash
50000
CY2019Q4 dcth Security For Credit Cards Restricted Cash
SecurityForCreditCardsRestrictedCash
50000
CY2020Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
389000
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
375000
CY2020Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
334000
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
279000
CY2020Q2 dcth Prepaid Clinical Trial Expenses Current
PrepaidClinicalTrialExpensesCurrent
1497000
CY2019Q4 dcth Prepaid Clinical Trial Expenses Current
PrepaidClinicalTrialExpensesCurrent
725000
CY2020Q2 us-gaap Prepaid Insurance
PrepaidInsurance
244000
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
589000
CY2020Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
251000
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
445000
CY2020Q2 dcth Maximum Percentage Of Prepaid Expenses And Other Current Assets
MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets
0.05
CY2019Q4 dcth Maximum Percentage Of Prepaid Expenses And Other Current Assets
MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets
0.05
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5467000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5246000
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4603000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4511000
CY2020Q2 dcth Property Plant And Equipment Depreciation Expense
PropertyPlantAndEquipmentDepreciationExpense
44000000
CY2019Q2 dcth Property Plant And Equipment Depreciation Expense
PropertyPlantAndEquipmentDepreciationExpense
57000000
dcth Property Plant And Equipment Depreciation Expense
PropertyPlantAndEquipmentDepreciationExpense
122000000
CY2020Q2 dcth Accrued Clinical Expenses Current
AccruedClinicalExpensesCurrent
2565000
CY2019Q4 dcth Accrued Clinical Expenses Current
AccruedClinicalExpensesCurrent
2497000
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
485000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
925000
CY2020Q2 dcth Maximum Percentage Of Current Liabilities Accrued
MaximumPercentageOfCurrentLiabilitiesAccrued
0.05
CY2019Q4 dcth Maximum Percentage Of Current Liabilities Accrued
MaximumPercentageOfCurrentLiabilitiesAccrued
0.05
us-gaap Lessor Operating Lease Description
LessorOperatingLeaseDescription
(i) the 2014 Sublease and 2015 Sublease were extended from May 31, 2020 to August 2, 2021, and (ii) effective July 1, 2020, the leased premises under the 2015 Sublease would be expanded to include an additional 4,999 square ft of space, and (ii) effective July 1, 2020, the rent under the 2015 Sublease would increase from approximately $14,559 per month to $20,643 per month
us-gaap Lessor Operating Lease Option To Extend
LessorOperatingLeaseOptionToExtend
May 31, 2020 to August 2, 2021
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
196.70
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
196.70
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2021-08-02
us-gaap Operating Lease Cost
OperatingLeaseCost
339000
dcth Financing Lease Cost
FinancingLeaseCost
23000
us-gaap Sublease Income
SubleaseIncome
98000
us-gaap Lease Cost
LeaseCost
264000
us-gaap Operating Lease Payments
OperatingLeasePayments
339000
us-gaap Proceeds From Lease Payments
ProceedsFromLeasePayments
98000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
344000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
200000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
544000
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
19000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
525000
CY2020Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
10.00
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
1549609
dcth Stock Issued During Period Shares Exercise Of Pre Funded Warrants
StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants
6000
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
72976
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1640
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1640
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1640
CY2020Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
196.70
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y1M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y7M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y7M6D
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0
CY2020Q2 dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
606000
CY2019Q2 dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
75000
dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
660000
dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
133000
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1826608
CY2019Q4 dcth Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
23.04
dcth Class Of Warrant Or Right Weighted Average Exercise Price Issued
ClassOfWarrantOrRightWeightedAverageExercisePriceIssued
10.00
dcth Class Of Warrant Or Right Weighted Average Exercise Price Exercises In Period
ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod
0.01
dcth Class Of Warrant Or Right Weighted Average Exercise Price Expirations In Period
ClassOfWarrantOrRightWeightedAverageExercisePriceExpirationsInPeriod
7.00
CY2020Q2 dcth Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
9.16
CY2019 dcth Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
P5Y
dcth Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
P4Y8M12D
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3368000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
2832000
dcth Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Fair Value Of Warrants Reclassified From Liability To Equity
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFairValueOfWarrantsReclassifiedFromLiabilityToEquity
6200000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6794514
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8329
dcth Number Of Shares Pre Funded Penny Warrants Outstanding
NumberOfSharesPreFundedPennyWarrantsOutstanding
371000
CY2020Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
2038297
CY2019Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
25587
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
1054549
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
26681
CY2020Q2 dcth Weighted Average Number Of Shares Pre Funded Warrants1
WeightedAverageNumberOfSharesPreFundedWarrants1
234890
CY2019Q2 dcth Weighted Average Number Of Shares Pre Funded Warrants1
WeightedAverageNumberOfSharesPreFundedWarrants1
76275
dcth Weighted Average Number Of Shares Pre Funded Warrants1
WeightedAverageNumberOfSharesPreFundedWarrants1
117445
dcth Weighted Average Number Of Shares Pre Funded Warrants1
WeightedAverageNumberOfSharesPreFundedWarrants1
76275
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2273187
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
101862
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1171994
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
102956

Files In Submission

Name View Source Status
0001564590-20-040037-index-headers.html Edgar Link pending
0001564590-20-040037-index.html Edgar Link pending
0001564590-20-040037.txt Edgar Link pending
0001564590-20-040037-xbrl.zip Edgar Link pending
dcth-10q_20200630.htm Edgar Link pending
dcth-20200630.xml Edgar Link completed
dcth-20200630.xsd Edgar Link pending
dcth-20200630_cal.xml Edgar Link unprocessable
dcth-20200630_def.xml Edgar Link unprocessable
dcth-20200630_lab.xml Edgar Link unprocessable
dcth-20200630_pre.xml Edgar Link unprocessable
dcth-ex311_9.htm Edgar Link pending
dcth-ex312_7.htm Edgar Link pending
dcth-ex321_6.htm Edgar Link pending
dcth-ex322_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending